What Inspired Us

Our Story


Providing Access
to Clinical Trials

Cohortias was formed because from a board member’s personal experience. After one of his close relatives was diagnosed with a then untreatable condition, he pursued alternative options in clinical research and discovered the lack of resources available in Latin America.

This motivated him to start a conversation between physicians and leaders in clinical research with an International CRO (Julius Clinical).

After a long period of planning and dialogue between the two, Cohortias was formed with one goal in mind: To provide the Latin American population with the opportunity to participate in potentially life saving treatments through clinical research.

“Transforming Lives through Clinical Research”

Martijn Wallert, CEO & Co-Founder

Rodrigo Salas Benavides

Board Member

In 2000 my wife was diagnosed with a deadly cancer called Gastro Intestinal Stromal Tumor (GIST). After a couple of surgeries we were informed that she had 6 months to live. She was 35 and we had 5 children. Our only option available was to participate in a clinical trial. After 3 months we found one slot at Dana Farber Cancer Institute in Boston. We were the only non-Americans participating in the trial. After two more surgeries, participation in 4 other studies and 6 years later, my wife lost her battle with cancer. Me and the kids we had the opportunity to enjoy 6 beautiful years as a family thanks to Clinical Research and the good work from professional doctors and institutions who were warriors in the field of oncology research.

Unfortunately, access to cutting edge clinical trials is less prevalent in Latin America, so I committed my life to bringing clinical trials to our region. My wish is to give the Latin American people the opportunity to participate in potentially life-saving treatments through clinical research. I was very proud that we were able to bring this dream to action with the formation of Cohortias International, for the future of research and advancement of medicine, one patient at a time.

Innovate in Latin America

Our Story

Cohortias International
  • Latin America (LATAM) is a region known for its diverse patient population, which makes it an attractive destination for clinical research. With a population that encompasses various ethnicities, age groups, and socioeconomic backgrounds, LATAM offers a rich pool of potential study participants.
  • Conducting clinical trials in LATAM presents unique advantages, including access to treatment-naive patients, which can provide valuable insights into the safety and efficacy of investigational drugs. Additionally, the region’s favorable regulatory environment and streamlined approval processes make it conducive to efficient study conduct.
  • With Cohortias, you gain access to our extensive network of research sites across LATAM, ensuring efficient and reliable study conduct. Our team of experienced professionals understands the nuances of conducting trials in the region and can navigate regulatory requirements with ease. Whether you’re seeking to expand your study into LATAM or looking for a partner to oversee the entire trial process, Cohortias has the expertise and resources to support your needs.
  • Our CRO partnering model is designed to foster collaborative relationships with sponsors, ensuring seamless communication and mutual success. We believe in working closely with our clients to understand their unique goals and challenges, allowing us to tailor our services to meet their specific needs.
  • At Cohortias, we view our clients as partners, and we strive to build long-term relationships based on trust, transparency, and shared objectives. Our team is committed to delivering high-quality services and providing proactive support throughout every stage of the clinical trial process.
  • By partnering with Cohortias, you benefit from our expertise in clinical trial management, regulatory compliance, and site selection. Whether you require assistance with study design, protocol development, site monitoring, or data management, we have the knowledge and experience to guide you through the complexities of the drug development process.
  • Cohortias specializes in high-enrollment rescue studies, helping sponsors overcome recruitment challenges and meet study timelines. We understand the critical importance of patient enrollment in the success of a clinical trial and employ innovative strategies to accelerate recruitment.
  • Our experienced team leverages a variety of recruitment tactics, including targeted advertising, patient advocacy groups, and physician referrals, to identify and enroll eligible participants. Additionally, our extensive network of research sites allows us to quickly mobilize resources and expand patient access to investigational treatments.
  • With Cohortias as your partner, you can expect rapid enrollment, efficient study execution, and timely data delivery. We are committed to helping you achieve your recruitment goals and ensuring the success of your clinical trial.
  • Conducting clinical trials in LATAM offers numerous benefits, including diverse patient populations, streamlined regulatory processes, and cost-effective trial conduct. The region’s multicultural demographics and varying disease prevalence rates provide researchers with access to a broad spectrum of patients, facilitating robust data collection and analysis.
  • Furthermore, LATAM boasts favorable regulatory frameworks that prioritize patient safety while supporting expedited trial approvals. This regulatory environment, coupled with lower operational costs compared to other regions, makes LATAM an attractive destination for sponsors seeking to conduct clinical research.
  • With Cohortias as your partner, you can tap into these benefits while ensuring high-quality data and efficient study execution. Our team of experts is well-versed in the regulatory requirements of LATAM countries and can navigate the intricacies of the local landscape to facilitate smooth trial conduct.
  • With over 20 years of experience in the industry, Cohortias has established itself as a trusted partner for sponsors seeking to conduct clinical trials in LATAM. Our extensive track record of success spans a wide range of therapeutic areas and study types, demonstrating our ability to deliver results across diverse projects.
  • Throughout our two decades in the industry, we have built strong relationships with sponsors, research sites, and regulatory authorities, enabling us to navigate the complexities of the drug development process with confidence. Our commitment to excellence and dedication to our clients’ success are the cornerstones of our approach.
  • Whether you’re conducting a phase I clinical trial or a large-scale phase III study, you can rely on Cohortias to provide the expertise, resources, and support needed to achieve your objectives. We are proud of our heritage and look forward to continuing our legacy of excellence in clinical research.